Apyx reaffirms $59.0M-$60.0M 2026 revenue guidance as AYON expands with FDA-cleared power liposuction

RegulatoryapprovedAYONPositive

AI Analysis

Summary

Apyx Medical reaffirms its 2026 revenue guidance of $59.0M-$60.0M while expanding its product portfolio with FDA clearance for AYON power liposuction device.

Financial Highlights

Guidance

$59.0M-$60.0M for 2026

Outcome Details

FDA-cleared power liposuction device

Importance:5/10

Sentiment:

0.60

medical devicesFDA clearancerevenue guidanceexpansion

Related Companies

$APYX

Read the original article

Published by Seeking Alpha Healthcare on August 7, 2026 12:25 PM

Read Original